Your browser doesn't support javascript.
loading
Neuropsychology practice guidance for the neuropsychiatric aspects of Long COVID.
Koterba, Christine H; Considine, Ciaran M; Becker, Jacqueline H; Hoskinson, Kristen R; Ng, Rowena; Vargas, Gray; Basso, Michael R; Puente, Antonio Enrique; Lippa, Sara M; Whiteside, Douglas M.
Afiliación
  • Koterba CH; Department of Neuropsychology, Nationwide Children's Hospital, Columbus, OH, USA.
  • Considine CM; Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, USA.
  • Becker JH; Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Hoskinson KR; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Ng R; Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, USA.
  • Vargas G; Center for Biobehavioral Health, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
  • Basso MR; Department of Neuropsychology, Kennedy Krieger Institute, Baltimore, MD, USA.
  • Puente AE; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Lippa SM; Department of Neuropsychology, Kennedy Krieger Institute, Baltimore, MD, USA.
  • Whiteside DM; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Clin Neuropsychol ; : 1-29, 2024 Aug 23.
Article en En | MEDLINE | ID: mdl-39177216
ABSTRACT

Objective:

The coronavirus disease-2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has had a profound global impact on individual health and well-being in adults and children. While most fully recover from COVID-19, a relatively large subgroup continues to experience persistent physical, cognitive, and emotional/behavioral symptoms beyond the initial infection period. The World Health Organization has termed this phenomenon "Post-COVID-19 Condition" (PCC), better known as "Long COVID." Due to the cognitive and psychosocial symptoms, neuropsychologists often assess and recommend treatment for individuals with Long COVID. However, guidance for neuropsychologists' involvement in clinical care, policy-making, and research has not yet been developed. The authors of this manuscript convened to address this critical gap and develop guidance for clinical neuropsychologists working with patients presenting with Long COVID.

Method:

Authors include pediatric and adult neuropsychologists with expertise in Long COVID and behavioral health. All authors have been engaged in clinical and research efforts examining the impact of COVID-19. Authors summarized the literature-to-date pertinent to the neuropsychiatric sequelae of Long COVID and developed guidance for neuropsychologists working with individuals with Long COVID.

Conclusions:

Research findings regarding neuropsychiatric symptoms associated with Long COVID are mixed and limited by methodological differences. As they practice and conduct research, neuropsychologists should remain mindful of the evolving and tenuous nature of the literature.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Neuropsychol Asunto de la revista: NEUROLOGIA / PSICOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Neuropsychol Asunto de la revista: NEUROLOGIA / PSICOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido